GRTX
Galera Therapeutics, Inc.
Latest Form 4:Sale$1KbySorensen Mel (President and CEO) · filed Nov 24, 2025
Galera Therapeutics, Inc. (GRTX) has 8 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 5, 2026.
- Industry:Biotechnology
- CEO:J. Mel Sorensen
- Employees:3
- HQ:Malvern, PA, US
- IPO:2019-11-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Sorensen MelFirst filing | President and CEO | Sale | 350 | $1K | Nov 24 | SEC ↗ |
Related companies
Galera Therapeutics, Inc. is in the Healthcare sector.